BioDelivery Sciences International Inc (NASDAQ:BDSI)

Data as of Oct 20
 +0.79 / +4.95%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

BioDelivery Sciences International, Inc. is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties. It is focusing on developing products to meet unmet patient needs in the areas of pain management and addiction. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.

Contact Information

BioDelivery Sciences International, Inc.
801 Corporate Center Drive
Raleigh North Carolina 27607
P:(919) 582-9050
Investor Relations:



Mutual fund holders39.20%
Other institutional26.91%
Individual stakeholders10.16%

Top Executives

Mark A. SirgoPresident, Chief Executive Officer & Director
Ernest R. de PaolantonioChief Financial Officer & Secretary
Niraj VasishtChief Technology Officer & SVP-Product Development
Adrian HepnerVP-Clinical Research & Regulatory Affairs
James A. McNultyTreasurer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.